Document is current
Any future updates will be listed below
-
Authors
Vaz-Pereira, Sara https://orcid.org/0000-0001-6125-5486
Morais-Sarmento, Tiago https://orcid.org/0000-0003-2648-3496
De Salvo, Gabriella https://orcid.org/0000-0002-1185-6942
- License Information
-
More Information
Article History
Received: 10 May 2021
Accepted: 21 September 2021
First Online: 26 October 2021
Declarations
:
: SVP reports consultant fees from Allergan, Alimera Sciences, Bayer, Novartis, and Roche, outside the submitted work. TMS has nothing to disclose. GDS reports consultant fees from Allergan, Bayer, Heidelberg Engineering and Novartis, outside the submitted work.
: Not applicable.
: All participants consented to the use of their anonymized data.
: This study was approved by Centro Hospitalar Universitário de Lisboa Norte, EPE—Hospital de Santa Maria local ethics committee (Lisbon, Portugal) and was conducted in accordance with the ethical principles of the Declaration of Helsinki. Informed consent was obtained from all participants.
